Assenagon Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9M | Sell |
1,711,595
-1,951,550
| -53% | -$42.1M | 0.05% | 241 |
|
|
2025
Q1 | $60.8M | Buy |
+3,663,145
| New | +$60.8M | 0.1% | 166 |
|
|
2022
Q3 | – | Sell |
-119,648
| Closed | -$1.69M | – | 1276 |
|
|
2022
Q2 | $1.69M | Sell |
119,648
-28,965
| -19% | -$408K | 0.01% | 871 |
|
|
2022
Q1 | $3.6M | Buy |
148,613
+47,464
| +47% | +$1.15M | 0.01% | 594 |
|
|
2021
Q4 | $2.36M | Buy |
101,149
+86,934
| +612% | +$2.03M | 0.01% | 731 |
|
|
2021
Q3 | $236K | Buy |
+14,215
| New | +$236K | ﹤0.01% | 1166 |
|
|
2019
Q4 | – | Sell |
-19,822
| Closed | -$713K | – | 702 |
|
|
2019
Q3 | $713K | Buy |
+19,822
| New | +$713K | ﹤0.01% | 590 |
|